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THE SPS AGREEMENT: CAN IT REGULATE 
TRADE IN NANOTECHNOLOGY? 
JAMES D. THAYER1
ABSTRACT 
Recent studies have shown that nanoparticles, which are 
approximately 1 to 100 billionths of a meter in size, present 
unique health and environmental risks.  Nevertheless, products 
enhanced by nanoparticles, such as sunscreen, golf balls, and 
hard drives, are shipped daily in international trade.  With these 
unique risks in mind, would measures regulating the trade in 
nanotechnology be subject to the WTO Agreement on Sanitary 
and Phytosanitary Measures?  If they were, would the 
Agreement objectively balance the unique risks and benefits of 
trading in nanotechnology?  Whether measures regulating the 
trade in nanotechnology are subject to the SPS Agreement 
depends on the purpose of such measures.  This iBrief argues 
that because of recent scientific evidence, many such measures 
are likely to be subject to the SPS Agreement.  In addition, since 
sanitary and phytosanitary measures must be based on scientific 
evidence, if Members apply the Agreement appropriately, the 
Agreement would objectively balance the benefits and risks of 
trading in nanotechnology.  
INTRODUCTION 
¶1 Despite all the hype regarding nanotechnology’s commercial 
potential, defining nanotechnology is difficult.  Nanotechnology 
originally meant molecular manufacturing but now encompasses a broad 
range of science and technology at the nanoscale,2 which is 
approximately 1 to 100 billionths of a meter.3  Molecular manufacturing, 
crudely defined, is the ability to create anything molecule-by-molecule.4  
Although manufacturing at this level is currently far from feasible, one 
                                                     
1 J.D./LL.M. (International Comparative Law), 2005, Duke University Law 
School; B.A. in International Studies: Global Trade, 2001, Brigham Young 
University.  The author would like to thank Dylan Williams for giving him the 
original idea for this article and Kathryn Nickerson and Professor Charles 
Verrill for their insight.   
2 K. Eric Drexler, Nanotechnology: From Feynman to Funding, BULL. OF SCI., 
TECH. & SOC’Y, Vol. 24, No. 1, at 21-27 (Feb. 2004),  available at 
http://www.metamodern.com/d/04/00/FeynmanToFunding.pdf.   
3 Los Alamos National Laboratory, Nanoscience and Nanotechnology (Feb. 
2004), at http://www.lanl.gov/news/pdf/NanoscienceFact.pdf.  
4 Drexler, supra note 2, at 1.   
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area where nanotechnology is used today is to enhance products.  In fact, 
products enhanced by nanoparticles are used daily by millions of people 
throughout the world.  Such products include sunscreens, cosmetics, 
tennis balls, stain-free clothing and mattresses, and hard drives.5   
¶2 Even though nanoparticles enhance products, recent scientific 
studies have shown that nanoparticles present unique and significant 
health risks.  For example, nanoparticles are small enough to pass 
through the blood-brain barrier in fish.6  It follows that overexposure of 
nanoparticles to humans may lead to the accumulation of lethal quantities 
of nanomaterial in the brain much like asbestos accumulates in the 
lungs.7   
¶3 Such potential health risks raise questions about how the 
international community should regulate trade in nanotechnology.  It 
took the international community almost 100 years to establish 
regulations for asbestos.8  How long will it take for nanotechnology?  
Perhaps current international health and safety standards are already 
applicable to measures regulating trade in this new technology.  If so, are 
they capable of balancing the unique risks and benefits of trading in 
nanotechnology?  Or, are new international standards necessary?  In 
addressing these issues, this iBrief analyzes the WTO Agreement on the 
Application of Sanitary and Phytosanitary Measures (“SPS 
Agreement”).9  It will also look at relevant WTO disputes, the most 
important being EC Measures Concerning Meat and Meat Products 
(“Hormone Beef”), the first WTO dispute to substantively deal with the 
SPS Agreement.10   
¶4 Like any trade protective measure, whether the SPS Agreement 
applies to measures prohibiting trade in nanotechnology depends on the 
measure’s purpose.11  The SPS Agreement applies to sanitary and 
                                                     
5 See Justin Gillis and Jonathan Krim, If It’s Nano, It’s BIG, Wash. Post, Feb. 
22, 2004, at F01. 
6 Eva Oberdörster, Manufactured Nanomaterials (Fullerenes, C60) Induce 
Oxidative Stress in the Brain of Juvenile Largemouth Bass, ENVTL. HEALTH 
PERSPECTIVES, vol. 112, num. 10, at 1058-1062 (July 2004), available at 
http://ehp.niehs.nih.gov/members/2004/7021/7021.pdf.
7 See id.   
8 See LONDON HAZARDS CENTRE, ASBESTOS HAZARDS HANDBOOK, chs. 12 & 
13 (1995), at http://www.lhc.org.uk/members/pubs/books/asbestos/asb_toc.htm. 
9 WTO Agreement on the Application of Sanitary and Phytosanitary Measures, 
Apr. 15, 1994, Marrakesh Agreement Establishing the World Trade 
Organization, Annex 1A (1994) [hereinafter SPS Agreement], 
http://www.wto.org/english/docs_e/legal_e/legal_e.htm#import.   
10 WTO Report of the Appellate Body on EC Measures Concerning Meat and 
Meat Products (Hormones) WT/DS26, 48/AB/R, [hereinafter Hormone Beef], 
http://www.wto.org/english/tratop_e/dispu_e/hormab.pdf (Jan. 16, 1998).   
11 SPS Agreement, supra note 9, Annex 1A.   
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phytosanitary measures (”SPS measures”), which are defined as 
measures whose purpose it is to protect animal, plant, or human health 
against certain risks associated with foreign goods.12   These risks 
include, among others, risks caused by toxins, diseases, and pests.13  
Since recent studies show that certain nanoparticles are toxic to fish,14 
the purpose of some measures regulating trade in nanotechnology will be 
to protect animal, plant, or human health against such risks.  In as much 
as they do, such measures would be subject to the SPS Agreement.   
¶5 In showing whether the SPS Agreement applies to 
nanotechnology, it is important to first define what nanotechnology is.  
This iBrief then considers the current state of nanotechnology and the 
different organizations that set international standards for this emerging 
field.  It then looks at the relevant trade law and how this law applies to 
nanotechnology.  The WTO Appellate Body decision in Hormone Beef 
has strengthened the requirement that SPS measures must be based on 
scientific evidence.15  Accordingly, this iBrief concludes that if Members 
apply the SPS Agreement appropriately, the Agreement would 
objectively balance the benefits and risks of trading in nanotechnology.  
I. NANOTECHNOLOGY 
A. Its Origins 
¶6 Nano means “extremely small” or “one-billionth” and is derived 
from the Greek word “nanos” meaning little old man or dwarf.16  In 
1986, K. Eric Drexler coined the term nanotechnology in his book 
Engines of Creation: the Coming Era of Nanotechnology. 17  In the 
glossary of the book, Drexler defines nanotechnology as “[t]echnology 
based on the manipulation of individual atoms and molecules to build 
structures to complex, atomic specifications.”18  In explaining 
nanotechnology, Drexler described an idea first expressed by renowned 
physicist Richard Feynman in his now classic 1959 address entitled 
There’s Plenty of Room at the Bottom.19  In the address, Feynman 
                                                     
12 See SPS Agreement, supra note 9, at Annex A1.   
13  Oberdörster, supra note 6.   
14 See id.   
15 See Hormone Beef, supra note 10.   
16 THE AMERICAN HERITAGE DICTIONARY OF THE ENGLISH LANGUAGE (4th ed., 
Houghton Mifflin Co. 2000), http://dictionary.reference.com/search?q=nano.   
17 K. ERIC DREXLER, ENGINES OF CREATION: THE COMING ERA OF 
NANOTECHNOLOGY (4th ed. 1994), available at 
http://www.foresight.org/EOC/index.html (last visited May 7, 2005).   
18 Id.     
19 See RICHARD P. FEYNMAN, PLENTY OF ROOM AT THE BOTTOM, Address to the 
American Physical Society at the California Institute of Technology, PUBLISHED 
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discussed the possibility of manipulating matter on the smallest scale, or 
the ability to artificially create at the atomic level - much like cells have 
been doing since life began:   
The principles of physics, as far as I can see, do not speak against 
the possibility of maneuvering things atom by atom . . . It would be, 
in principle, possible . . . for a physicist to synthesize any chemical 
substance that the chemist writes down. . . . How? Put the atoms 
down where the chemist says, and so you make the substance. The 
problems of chemistry and biology can be greatly helped if our 
ability to see what we are doing, and to do things on an atomic 
level, is ultimately developed - a development which I think cannot 
be avoided.20
¶7 If possible, Feynman’s idea would mean nations with this 
capability could build practically anything, molecule-by-molecule.  In 
addition, some believe that this development could eventually lead to the 
end of the world: uncontrollable self-replicating nano sized robots would 
turn the earth into “gray goo.”  Drexler described one version of the 
“gray goo” concern where nano plants “with ‘leaves’ no more efficient 
than today’s solar cells could out-compete real plants, crowding the 
biosphere with an inedible foliage.”21 
¶8 Despite Drexler’s use of nanotechnology to express Feynman’s 
original idea, the term nanotechnology now “embraces a broad range of 
science and technology working at a length scale approximately 1 to 100 
nanometers, including the more specific goal [of molecular 
manufacturing] it originally denoted.”22   
B. Current Developments 
¶9 There are also at least 30 different countries developing 
initiatives to promote and exploit nanotechnologies.23  For example, in 
2003 Congress passed the 21st Century Nanotechnology Research and 
Development Act.24  This Act created the National Nanotechnology 
Initiative (“NNI”), and the Act provides $3.7 billion25 for the next three 
years for the NNI to “coordinate the multiagency effort in nanoscale 
                                                                                                                       
ENGINEERING AND SCIENCE (Dec. 1959), available at 
http://www.its.caltech.edu/~feynman/plenty.html (last visited May 10, 2005).   
20 Engines of Creation, supra note 17, at 215.   
21 Id. 
22 Drexler, supra note 2.   
23 M.C. Roco, Government Nanotechnology Funding: An International Outlook, 
National Science Foundation (June 30, 2003), at 
http://www.nano.gov/html/res/IntlFundingRoco.htm.   
24 21st Century Nanotechnology Research and Development Act, Pub. L. No. 
108-153 (S. 189), §§ 1-10 (2003) (codified at 15 U.S.C. §§ 7501-09).   
25 Id. (§ 6 appropriations add up to approx. $3.7 billion).   
  
2005 DUKE LAW & TECHNOLOGY REVIEW No. 15 
science, engineering and technology.”26  In addition to the NNI, there are 
at least 52 different nanotechnology research and education centers 
throughout the United States.27   
¶10 Although most U.S. and foreign nanotechnology initiatives are 
created to study the commercial uses of nanotechnology, some groups 
are realizing the need to study the potential health risks, as well.  For 
example, the Environmental Protection Agency (“EPA”) recently gave 
$4 million to 12 different universities to study the potential 
environmental and health risks of nanomaterials.28  In its announcement, 
the EPA said that there is currently “very limited scientific information 
on the effects of nanomaterials on human health and the environment.”29   
¶11 Toxicologist Dr. Eva Oberdörster has provided important 
contributions to this limited set of scientific information with studies 
showing that certain nanoparticles are harmful to forms of aquatic life.30  
One study showed that modest concentrations of fullerenes, synthetic, 
soccer ball-like, nanosized carbon molecules, in water eventually killed 
water fleas.31  Another Oberdörster’s study showed that fullerenes caused 
brain damage in largemouth bass.32  This study led Oberdörster to 
believe that the nanoparticles may have also killed beneficial bacteria in 
the water where the fish were tested.33  Oberdörster’s research is unique 
because it is the first research to examine the possible effects of releasing 
synthetic nanoparticles into the environment.34  Other studies have also 
shown that nanoparticles have toxic effects on living matter: for 
example, in 2003, researchers found that nanotubes, a specific type of 
nanoparticle, damaged lung tissue in mice.35   
¶12 In light of these studies, some industries have urged scientists 
and policy makers to proceed with caution on the quest for harnessing 
                                                     
26 NNI, About the NNI, at http://www.nano.gov/html/about/home_about.html 
(last visited Mar. 19, 2005).     
27 NNI, Links, at http://www.nano.gov/html/res/links.html (last visited Mar. 19, 
2005).     
28 Press Advisory, Environmental Protection Agency, $4 million in Grants to 
Research Environmental Impact of Nanotechnology (Nov. 12, 2004), at 
http://www.epa.gov/cgi-bin/epaprintonly.cgi.  Fullerenes are often called 
“buckyballs” because they look like the “famous geodesic dome of R. 
Buckminster Fuller, the visionary architect and scientist.”  Gills, supra note 5.   
29 Id.   
30 Oberdörster, supra note 6.   
31 Id. at 1059-61.   
32 Id.   
33 Id. at 1059.   
34 Id.   
35 Bob Holmes, Buckyballs Cause Brain Damage in Fish, NEW SCIENTIST (Mar. 
29, 2004), at http://www.newscientist.com/news/news.jsp?id=ns99994825.    
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nanotechnology.36  In May 2004, Swiss Re, one of the world’s largest 
insurance companies, published a report on the risks of nanotechnology 
containing a list of potential issues that it thought needed to be addressed 
before significant developments in nanotechnology should continue.37  
However, in July 2004, a report38 commissioned by the United Kingdom 
concluded that many new nano-sciences and -technologies do not present 
unique risks to health, safety or the environment.39     
¶13 Whether such reports are taken into consideration in establishing 
U.S. nanotechnology policy depends on a number of federal agencies.  
The U.S. Department of Agriculture (“USDA”) works with the three 
main international bodies responsible for setting standards relating to the 
SPS Agreement: (1) the Codex Alimentarius Commission, responsible 
for food safety;40 (2) the Office Internationale des Epizooties, responsible 
for animal health;41 and (3) the Secretariat of the International Plant 
Protection Convention, responsible for plant health.42  The USDA’s U.S. 
Codex Office of the Food Safety and Inspection Service (“FSIS”) 
coordinates U.S. relations with the Codex Alimentarius Commission.43  
The FSIS is the public health agency of the USDA,44 and is responsible 
for ensuring that the United States’ commercial supply of meat, poultry, 
and egg products is safe and correctly packaged and labeled.45   
¶14 The Animal and Plant Health Inspection Service (“APHIS”) of 
the USDA is responsible for coordination with the Secretariat of the 
International Plant Protection Convention and the Office Internationale 
                                                     
36 SWISS RE, NANOTECHNOLOGY - SMALL MATTER, MANY UNKNOWNS (May 
2004), http://www.swissre.com/internet/pwswpspr.nsf/alldocbyidkeylu/ulur-
5yaffs.   
37 Id.   
38THE ROYAL SOCIETY AND THE ROYAL ACADEMY OF ENGINEERING, 
NANOSCIENCE AND NANOTECHNOLOGIES: OPPORTUNITIES AND UNCERTAINTIES 
(July 29, 2004), at http://www.nanotec.org.uk/finalReport.htm.   
39 Id. at para. 8.1.3, http://www.nanotec.org.uk/report/chapter8.pdf.   
40 Codex Amlimentarius Commission, at 
http://www.codexalimentarius.net/web/index_en.jsp (last visited April 6, 2005).    
41 Office Internationale des Epizooties, What is OIE?, at 
http://www.oie.int/eng/OIE/en_oie.htm (last visited April 6, 2005).    
42 See International Phytosanitary Portal, at 
https://www.ippc.int/IPP/En/default.jsp (last visited April 6, 2005).   
43 FOOD SAFETY AND INSPECTION SERVICE, Regulations and Policies, 
International Affairs, Codex Alimentarius, at 
http://www.fsis.usda.gov/Regulations_&_Policies/Codex_Alimentarius/index.as
p (last visited Mar. 19, 2005).   
44 FOOD SAFETY AND INSPECTION SERVICE, About FSIS, at 
http://www.fsis.usda.gov/About_FSIS/index.asp (last visited Mar. 19, 2005). 
45Id.      
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des Epizooties.46  The APHIS assesses and regulates the risks associated 
with agricultural imports.47  
II. APPLICABLE LAWS 
¶15 In 1947, several countries enacted the General Agreement on 
Tariffs and Trade (“GATT”) to reduce tariffs and increase world trade.48  
On January 1, 1995, the World Trade Organization (“WTO”) replaced 
the GATT as the organization overseeing the “multilateral trading 
system.”49 While the GATT has been very successful in reducing tariff 
barriers,50  the practical effect of the GATT has been lessened because its 
Members have resorted to non-tariff trade barriers to skirt their 
obligations.  For example, Article XX of the GATT allows for protective 
measures that protect human, animal, or plant health has been widely 
exploited.51  Ironically, these same Members created the SPS Agreement 
to reduce such non-tariff barriers to trade.52   
A. The SPS Agreement 
¶16 The SPS Agreement has two main goals: (1) allowing Members 
to maintain the level of health protection they consider appropriate; and 
(2) ensuring that sanitary and phytosanitary (“SPS”) measures are not 
unnecessary, arbitrary, or scientifically unjustifiable.53  To achieve these 
objectives the SPS Agreement only applies to SPS measures, and 
requires that SPS measures that are not following international standards 
conduct a risk assessment that is rationally related to scientific evidence.  
                                                     
46 ANIMAL AND PLANT HEALTH INSPECTION SERVICE, Overview, International 
Services, at http://www.aphis.usda.gov/is/pages/overview.htm (last visited April 
6, 2005).   
47 See id.   
48 See WTO, SPS Agreement Training Module: Introduction to the SPS 
Agreement, at 
http://www.wto.org/english/tratop_e/sps_e/sps_agreement_cbt_e/c1s1p1_e.htm 
[hereinafter SPS Introduction] (last visited April 6, 2005).  
49 WTO, http://www.wto.org/english/thewto_e/gattmem_e.htm (last visited May 
9, 2005).  Most of the GATT’s substantive provisions were incorporated into the 
WTO.   
50 See World Trade Organization, The WTO in Brief, at 
http://www.wto.org/english/thewto_e/whatis_e/inbrief_e/inbr01_e.htm (last 
visited April 6, 2005).   
51 General Agreement on Tariffs and Trade, Oct. 30, 1947 [hereinafter 
“GATT”], art. XX (1994).  
52 See World Trade Organization, SPS Agreement Training Module: 
Background, at 
http://www.wto.org/english/tratop_e/sps_e/sps_agreement_cbt_e/intro1_e.htm 
(last visited April 6, 2005).   
53 SPS Introduction, supra note 48.   
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Lastly, the Agreement allows for countries to take temporary 
precautionary measures in the face of uncertain risk.    
1. Scope 
¶17 The SPS Agreement applies only to WTO Members.  Moreover, 
it states in its first article that the agreement applies to “all sanitary and 
phytosanitary measures which may, directly or indirectly, affect 
international trade.”54  Considering the global economy, the requirement 
that these measures affect international trade is in practice not difficult to 
satisfy.  This analysis assumes that this requirement is met.  The more 
difficult question is what constitutes a sanitary or phytosanitary measure.  
According to Annex A1 of the SPS Agreement, whether a measure 
prohibiting trade is a sanitary or phytosanitary measure depends on its 
purpose.55  Annex A1 specifically mentions four purposes that satisfy 
this requirement:    
(a) to protect animal or plant life or health . . . from risks arising 
from . . . pests, diseases, disease-carrying organisms or disease-
causing organisms;   
(b) to protect human or animal life or health . . . from risks arising 
from additives, contaminants, toxins or disease-causing organisms 
in foods, beverages or feedstuffs;   
(c) to protect human life or health . . . from risks arising from 
diseases carried by animals, plants or products thereof, or from the 
entry, establishment or spread of pests; or   
(d) to prevent or limit other damage . . . from the entry, 
establishment or spread of pests. 56
The form of the measure is not important in determining whether it is a 
SPS measure.57  For example, SPS measures include even technical 
measures, such as labeling requirements, if they are created to protect 
human life from the risks arising from toxins.58   
¶18 Few Appellate Body decisions and panel reports discuss the 
scope of the SPS Agreement.  In Australia – Measures Affecting 
Importation of Salmon (“Australia – Salmon”), however, a WTO 
panel examined whether an Australian prohibition on imports of dead 
                                                     
54 SPS Agreement, supra note 9, art. 1.1.   
55 Id. Annex A1. 
56 Id.   
57 WTO, SPS Agreement Training Module: Introduction to the SPS Agreement, 
1.4 SPS and TBT measures, at 
http://www.wto.org/english/tratop_e/sps_e/sps_agreement_cbt_e/c1s4p1_e.htm 
(last visited April 6, 2005).   
58 Id.   
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salmon was a “sanitary measure” within the meaning of paragraph 1(a) 
and (b) of Annex A1 of the SPS Agreement.59   The panel found that 
Australia’s prohibition was within the scope of the SPS Agreement under 
paragraph 1(a) because the purpose of the measure was to protect 
Australia’s fish from exotic disease.60  Once it is found that the SPS 
Agreement applies to a specific measure, whether the measure is based 
on scientific evidence or an international standard must be determined.   
2. Scientific evidence and the risk assessment 
¶19 If an SPS measure is not based on an international standard, the 
Member must show it is based on a risk assessment.61  A risk assessment 
requires that Members “ensure that their sanitary or phytosanitary 
measures are based on an assessment, as appropriate to the 
circumstances, of the risks to human, animal or plant life or health, 
taking into account risk assessment techniques developed by the relevant 
international organizations.”62  It further requires that Members take 
available scientific evidence into account.63  In Hormone Beef, the WTO 
Appellate Body determined that Article 2.2 of the SPS Agreement 
informs Article 5.1.64  Article 2.2 requires that SPS measures be based on 
scientific principles and maintained with sufficient scientific evidence, 
while Article 5.1 requires that Members ensure their SPS measures are 
based on a risk assessment.65  The Appellate Body found further that 
Article 2.3 informs Article 5.5.  Article 2.3 requires that SPS measures 
do not unjustifiably discriminate between Members and that they are not 
applied in a way that would constitute a disguised restriction on trade, 
and Article 5.5 requires that Members avoid arbitrary and unjustifiable 
distinctions in SPS protection levels for different situations.66  These 
findings solidify the importance of scientific evidence as a requirement 
of the SPS Agreement when measures are not based on international 
standards.   
3. Harmonization with international standards  
¶20 With few exceptions, the SPS Agreement requires Members to 
base SPS measures on existing international standards.  The SPS 
Agreement explicitly recognizes the standards set by the three 
                                                     
59 Australia – Measures Affecting Importation of Salmon, Recourse to Article 
21.5 by Canada, WT/DS18/RW [hereinafter Australia – Salmon] (Feb. 18, 
2000), available at http://www.worldtradelaw.net/reports/wtopanels/australia-
salmon(panel)(21.5).pdf. 
60 See id. para. 2.3.   
61 SPS Agreement, supra note 9, art. 5.1.   
62 Id.   
63 Id. art. 5.2.   
64 Hormone Beef, supra note 10, paras. 180-81.   
65 Id.   
66 Id. para. 250.     
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international standard setting bodies mentioned above: (1) the Codex 
Alimentarious Commission, for food safety; (2) the Office Internationale 
des Epizooties, for animal health; and (3) the Secretariat of the 
International Plant Protection Convention, for plant health.67  The 
WTO’s SPS Committee oversees harmonization of domestic measures 
with international standards by working directly with these three 
bodies.68   
4. Precaution and the precautionary principle 
¶21 Article 5.7 of the SPS Agreement allows Members to use some 
precaution when enacting SPS measures.69  Specifically, it permits 
countries to adopt provisional SPS measures in cases where relevant 
scientific evidence is not sufficient to establish the safety or threat of a 
good.70  These provisional measures must be based on available pertinent 
information.71  This information includes that from relevant international 
organizations and from SPS measures applied by other Members.72  In 
such circumstances, Members must seek to obtain the additional 
information necessary for a more objective assessment of risk and review 
the SPS measure accordingly within a reasonable time.73  Provisional 
measures are permitted only until sufficient evidence is available to 
either justify or condemn the measures.  
B. Other WTO Disputes  
¶22 Members have only brought a few disputes before the WTO 
regarding the SPS Agreement.  The most important dispute, Hormone 
Beef, was brought by the United States and Canada against the European 
Communities challenging the E.C.’s ban on the importation of hormone 
treated beef.   The WTO Appellate Body found that the E.C.’s measures 
prohibiting the importation of hormone treated beef were in violation of 
Article 5.1 of the SPS Agreement because they were not rationally 
related to a risk assessment.74  Although the original panel was requested 
to hear the dispute in 1996 and the Appellate Body’s report was adopted 
in 1998, the European Communities still has not complied with the 
                                                     
67 SPS Agreement, supra note 9, art. 3.   
68 See id. art. 3.5.   
69 See id. art. 5.7. 
70 See id.   
71 Id.   
72 Id.   
73 Id.     
74 Hormone Beef, supra note 10, paras. 208-209.   
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Appellate Body report.75  After almost 10 years, the dispute is still 
disrupting trade.76 
¶23 Another WTO dispute dealing with the SPS Agreement is Japan 
– Measures Affecting Agricultural Products (“Japan – Agricultural 
Products”).77  There, the Appellate Body identified four requirements 
Members must meet to comply with Article 5.7.78  Members may 
provisionally adopt an SPS measure if the measure is (1) imposed in 
response to insufficient scientific information; and (2) adopted “on the 
basis of available pertinent information.”  After imposing provisional 
measures, Members must also (3) seek additional information necessary 
for a more objective risk assessment; and (4) review the measure within a 
reasonable period of time.79  The Appellate Body stated further that 
“Article 5.7 operates as a qualified exemption from the obligation under 
Article 2.2 not to maintain SPS measures without sufficient scientific 
evidence. An overly broad and flexible interpretation of that obligation 
would render Article 5.7 meaningless.”80  
¶24 The most recent WTO dispute alleging violations of the SPS 
Agreement is European Communities – Measures Affecting the 
Approval and Marketing of Biotech Products (“EC – Biotech 
Products”).81  The WTO has not yet released a panel report regarding 
this dispute.  Here, the United States alleges the E.C. moratorium on the 
approval of products of agricultural biotechnology (“biotech products”) 
violates, among other agreements, the SPS Agreement.  Specifically, the 
U.S. alleges that the E.C. moratorium imposes an undue delay to its 
biotech procedures.  Furthermore, many of the products “caught up in the 
E.C. moratorium have been positively assessed by the E.C.’s own 
scientific committees.”82  Since the WTO has not yet issued a report on 
                                                     
75 See Bridges: Weekly Trade New Digest, EC beef hormone dispute drags on 
(Nov. 13, 2003), at http://www.ictsd.org/weekly/03-11-13/story3.htm.   
76 Id.   
77 Japan – Measures Affecting Agricultural Products WT/DS76/AB/R (Feb. 22, 
1999) [hereinafter Japan – Agricultural], available at 
http://www.worldtradelaw.net/reports/wtoab/japan-agproducts(ab).pdf.   
78 WTO, Analytical Index, SPS Agreement, art. 5.7, para. 115, available at 
http://www.wto.org/english/res_e/booksp_e/analytic_index_e/sps_02_e.htm#arti
cle5B6 (last visited Mar. 19, 2005).      
79 Japan – Agricultural, supra note 77, para. 89.   
80 Id. para. 80.   
81 European Communities – Measures Affecting the Approval and Marketing of 
Biotech Products WT/DS291/23, Request for the Establishment of a Panel by 
the United States (Aug. 8, 2003), available at 
http://www.worldtradelaw.net/pr/ds291-23(pr).pdf.   
82 European Communities – Measures Affecting the Approval and Marketing of 
Biotech Products WT/DS291, 292, and 293, Executive Summary of the First 
Submission of the United States, para. 4 (April 30, 2004), available at 
http://www.ustr.gov/assets/Trade_Agreements/Monitoring_Enforcement/Disput
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this issue, it is less relevant to the discussion of nanotechnology and the 
SPS Agreement than other WTO disputes.    
III. THE SPS AGREEMENT AND NANOTECHNOLOGY 
A. Would the SPS Agreement apply to measures regulating trade in 
nanotechnology?   
¶25 Whether the SPS Agreement applies to measures regulating trade 
in nanotechnology ultimately depends on the purpose of the specific 
measures.  The SPS Agreement applies to all “sanitary and phytosanitary 
measures which may, directly or indirectly, affect international trade.”83  
Assuming measures regulating trade in nanotechnology affect 
international trade, they are subject to the SPS Agreement if they are SPS 
measures.  They are SPS measures if they have any of the four purposes 
identified in Annex A1 of the SPS Agreement, discussed in section IIA 
above.  The first three provisions generally have two requirements: to 
protect different kinds of life from various health risks.  The fourth 
category seeks to prevent damage by pests.   
¶26 Given Dr. Oberdörfer’s studies showing the toxicity of some 
nanoparticles to fish, it is easy to imagine measures regulating 
nanotechnology with the purpose of protecting animal or human life 
from toxins in foods, beverages or feedstuffs.  Such measures would 
satisfy the requirements of category (b) above and, therefore, be subject 
to the SPS Agreement.  Moreover, the first question of whether such 
measures would have the requisite purpose of protecting animal or 
human life is an abstract question because we do not have specific 
measures to analyze.  However, as shown by Hormone Beef and 
Australia - Salmon, the purpose of protective measures is generally not 
disputed.  That is, if a Member says the purpose of a measure is to 
protect or fish from diseases, this assertion is generally not challenged.  
The second question, whether nanotechnology is a toxin, is also not 
difficult to answer.  Considering Dr. Oberdörfer’s studies, it is hard to 
imagine that measures prohibiting the trade of fullerenes would not 
satisfy this category.  Oberdörfer has shown that fullerenes are toxic to 
large mouth bass.84   
¶27 Other provisions of Annex 1A present more difficult questions.  
For example, category (a) includes any measure with the purpose of 
                                                                                                                       
e_Settlement/WTO/Dispute_Settlement_Listings/asset_upload_file737_5542.pd
f. 
83 SPS Agreement, supra note 9, art. 1.1.   
84 However, a similar measure regulating the trade of all nanotechnology might 
not be so easily justifiable.  Are all nanotechnologies toxic to human or animal 
life?  Such factual questions, although important, are beyond the scope of this 
iBrief.     
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protecting animal or plant life or health from risks from pests or diseases, 
including disease -carrying or-causing organisms.  Are nanoparticles 
pests?  Are they diseases?  Or, do they cause disease and, thus, also 
satisfy the requirement?  What about measures that regulate the trade in a 
different type of nanotechnology?  For example, Drexler’s example of 
the gray goo problem sounds a lot like a pest:   “‘Plants’ with ‘leaves’ no 
more efficient than today’s solar cells could out-compete real plants, 
crowding the biosphere with an inedible foliage.”85  Category (d) also 
raises the question of whether nanotechnology is a pest.   
¶28 In addition, category (c) encompasses any measure whose 
purpose it is to protect humans from the risks of diseases carried by 
animals, plants or products thereof, or from pests.  This again raises 
some of the same questions mentioned above: are nanoparticles diseases, 
or do they cause disease?  What about nanotechnology as a whole?  If 
nanoparticles are not themselves considered toxins but cause diseases, 
measures regulating their trade would be subject to the SPS Agreement.  
To answer these questions one must examine the nature of the specific 
nanotechnology in question.  Moreover, in the case of nanoparticles, 
specifically fullerenes, these questions may be avoided by looking at the 
ostensibly more straightforward questions presented by category (b) of 
Annex A1.   
¶29 WTO jurisprudence provides little help in determining whether 
nanotechnology or nanoparticles are pests, diseases, disease-carrying 
organisms or disease-causing organisms.  The only WTO ruling that 
expounds Annex A1 is Australia - Salmon.  There, Australia banned the 
importation of fresh, chilled or frozen salmon that had not been heat 
treated to protect against 24 known disease agents.86  The panel 
implicitly acknowledged without discussion that the measure was subject 
to the SPS Agreement.  The only discussion was directed towards 
determining which provision of Annex A1 covered the measure.  The 
panel found that because of “the objectives for which the measure is 
being applied,” it was a “‘sanitary measure’” under the definition of 
paragraph 1(a) of Annex A1.87 The panel ruling reinforces the language 
of Annex A1 stating that any measure whose objective is to protect 
humans, animals, or plants from the risks specified in the SPS 
Agreement is considered an SPS measure and subject to the SPS 
Agreement.   
¶30 Hormone Beef also sheds some light on the question.  There, the 
European Communities banned the importation of meat and meat 
                                                     
85 Engines of Creation, supra note 17, at 215.   
86 Australia - Measures Affecting Importation of Salmon, WT/DS18/R, paras. 
1.1 & 2.11 (June 12, 1998), available at 
http://www.worldtradelaw.net/reports/wtopanels/australia-salmon(panel).pdf. 
87 Id. para. 8.34.   
  
2005 DUKE LAW & TECHNOLOGY REVIEW No. 15 
products from cattle treated with any of six specific hormones for growth 
purposes.  The explicit purpose of these measures was to protect human 
health.  Both parties agreed that the measures were subject to the SPS 
Agreement according to Paragraph 1(b) of Annex A: “ ‘any measure 
applied to protect human . . . health . . . from risks arising from additives, 
contaminants, toxins or disease-causing organisms in food, beverages or 
feedstuffs.’”88  The panel agreed with the parties.  It said the E.C. 
measures were applied to protect human life or health from risks arising 
from contaminants, “namely residues of six specific hormones, in 
foods.”89  The panel noted that footnote 4 to Annex A specified that 
“contaminants” includes “pesticide and veterinary drug residues and 
extraneous matter.”  The panel concluded that “[s]ince the six hormones 
in dispute are veterinary drugs, the parties agree that the alleged risks at 
issue arise from contaminants.”90 
 
¶31 Considering recent scientific evidence, measures that regulated 
the trade in nanotechnology with the purpose of protecting human or 
animal life from toxins would be subject to the SPS Agreement.   
B. Would the SPS Agreement provide an objective balance between 
the risks and benefits of trading in nanotechnologies?91   
¶32 Because the SPS Agreement requires Members to base their SPS 
measures on scientific evidence, the Agreement would provide an 
objective balance between the risks and benefits of trading in 
nanotechnology.92  According to Article 2.2, Members must ensure that 
their SPS measures are “based on scientific principles and [are] not 
maintained without sufficient scientific evidence.”93    In addition, 
Members must ensure their SPS measures “do not arbitrarily or 
unjustifiably discriminate between Members,” and that their SPS 
                                                     
88 EC Measures Concerning Meat and Meat Products (Hormones) Complaint by 
the United States Report of the Panel WT/DS26/R/USA, para. 8.21 (Aug. 18, 
1997) [hereinafter Hormone Beef Complaint], available at 
http://www.worldtradelaw.net/reports/wtopanels/ec-hormones(panel)(us).pdf.   
89 Id. para. 8.22.   
90 Id. para. 8.21.   
91 In practice, the answer to this question depends on how individual Members 
interpret the obligations created by the SPS Agreement.  For example, in 
Hormone Beef, the European Communities dismissed the SPS Agreement’s 
requirement to base SPS measures on scientific evidence.  They disagreed with 
the United States and the WTO Appellate Body on how precaution should play a 
role in the risk assessment.  For the SPS Agreement to objectively regulated 
trade in nanotechnologies, the European Communities and the United States 
need to reconcile their differences regarding the role of precaution under the 
SPS Agreement.       
92 SPS Agreement, supra note 9, art. 2.2.   
93 Id.     
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measures are not applied in a manner that would constitute a disguised 
restriction on trade.94  Although this article has not been adjudicated at 
the WTO, the Appellate Body in Hormone Beef held that Article 2.3 is 
part of the risk assessment of Article 5.5.95  Article 2.3 play an important 
role in future WTO disputes.   
¶33 In the case of nanoparticles, especially fullerenes, it seems that 
preliminary measures under Article 5.7 could be based on scientific 
evidence, specifically the Oberdörster study.  In light of how long it took 
the international community to effectively regulate asbestos it would 
seem that protective measures regulating the trade in potentially harmful 
nanoparticles would be welcome.   
CONCLUSION 
¶34 Nanotechnology is becoming more important each day.  This 
includes both the development of and trade in goods containing 
nanoparticles and the progress made towards the specific goal of 
molecular manufacturing.  Although such developments bring immediate 
benefits to consumers and investors in the form of, for example, longer 
lasting tennis balls and loftier golf balls, they also bring significant risks.  
In light of these risks, nations will inevitably establish measures that 
regulate the trade in nanotechnology.  Considering recent scientific 
evidence, measures that regulated the trade in nanotechnology with the 
purpose of protecting human or animal life from toxins would be subject 
to the SPS Agreement.  If this is the case, the agreement’s reliance on 
scientific evidence would provide for an objective balance between the 
risks and benefits in trading in nanotechnology. 
                                                     
94 Id. art. 2.3. 
95 Hormone Beef, supra note 10, paras. 180-81.   
  
